360 related articles for article (PubMed ID: 22484007)
61. Photoisomerizable arylstilbazolium ligands recognize parallel and antiparallel structures of G-quadruplexes.
Czerwinska I; Juskowiak B
Int J Biol Macromol; 2012 Nov; 51(4):576-82. PubMed ID: 22750579
[TBL] [Abstract][Full Text] [Related]
62. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.
Hurley LH; Von Hoff DD; Siddiqui-Jain A; Yang D
Semin Oncol; 2006 Aug; 33(4):498-512. PubMed ID: 16890804
[TBL] [Abstract][Full Text] [Related]
63. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
[TBL] [Abstract][Full Text] [Related]
64. Identifying G-quadruplex-binding ligands using DNA-functionalized gold nanoparticles.
Qiao Y; Deng J; Jin Y; Chen G; Wang L
Analyst; 2012 Apr; 137(7):1663-8. PubMed ID: 22331167
[TBL] [Abstract][Full Text] [Related]
65. Synthesis and binding studies of novel di-substituted phenanthroline compounds with genomic promoter and human telomeric DNA G-quadruplexes.
Wei C; Wang Y; Zhang M
Org Biomol Chem; 2013 Apr; 11(14):2355-64. PubMed ID: 23429572
[TBL] [Abstract][Full Text] [Related]
66. New quinazoline derivatives for telomeric G-quadruplex DNA: effects of an added phenyl group on quadruplex binding ability.
He JH; Liu HY; Li Z; Tan JH; Ou TM; Huang SL; An LK; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2013 May; 63():1-13. PubMed ID: 23454529
[TBL] [Abstract][Full Text] [Related]
67. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
68. Methods for investigating G-quadruplex DNA/ligand interactions.
Murat P; Singh Y; Defrancq E
Chem Soc Rev; 2011 Nov; 40(11):5293-307. PubMed ID: 21720638
[TBL] [Abstract][Full Text] [Related]
69. Biophysical studies of the c-MYC NHE III1 promoter: model quadruplex interactions with a cationic porphyrin.
Freyer MW; Buscaglia R; Kaplan K; Cashman D; Hurley LH; Lewis EA
Biophys J; 2007 Mar; 92(6):2007-15. PubMed ID: 17172304
[TBL] [Abstract][Full Text] [Related]
70. Synthesis, structural characterization, and quadruplex DNA binding studies of platinum(II)-terpyridine complexes.
Suntharalingam K; White AJ; Vilar R
Inorg Chem; 2009 Oct; 48(19):9427-35. PubMed ID: 19728717
[TBL] [Abstract][Full Text] [Related]
71. Quadruplex-duplex competition in the nuclease hypersensitive element of human c-myc promoter: C to T mutation in C-rich strand enhances duplex association.
Halder K; Mathur V; Chugh D; Verma A; Chowdhury S
Biochem Biophys Res Commun; 2005 Feb; 327(1):49-56. PubMed ID: 15629428
[TBL] [Abstract][Full Text] [Related]
72. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
73. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
74. Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay.
Jin Y; Li H; Bai J
Anal Chem; 2009 Jul; 81(14):5709-15. PubMed ID: 19527045
[TBL] [Abstract][Full Text] [Related]
75. Structure of the biologically relevant G-quadruplex in the c-MYC promoter.
Yang D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):951-68. PubMed ID: 16901825
[TBL] [Abstract][Full Text] [Related]
76. 9-Substituted berberine derivatives as G-quadruplex stabilizing ligands in telomeric DNA.
Zhang WJ; Ou TM; Lu YJ; Huang YY; Wu WB; Huang ZS; Zhou JL; Wong KY; Gu LQ
Bioorg Med Chem; 2007 Aug; 15(16):5493-501. PubMed ID: 17574421
[TBL] [Abstract][Full Text] [Related]
77. Studies on characterization, telomerase inhibitory properties and G-quadruplex binding of η6-arene ruthenium complexes with 1,10-phenanthroline-derived ligands.
Sun D; Zhang R; Yuan F; Liu D; Zhou Y; Liu J
Dalton Trans; 2012 Feb; 41(6):1734-41. PubMed ID: 22159049
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands.
Ma Y; Ou TM; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
Bioorg Med Chem Lett; 2009 Jul; 19(13):3414-7. PubMed ID: 19477640
[TBL] [Abstract][Full Text] [Related]
79. Polycyclic azoniahetarenes: assessing the binding parameters of complexes between unsubstituted ligands and G-quadruplex DNA.
Jäger K; Bats JW; Ihmels H; Granzhan A; Uebach S; Patrick BO
Chemistry; 2012 Aug; 18(35):10903-15. PubMed ID: 22807262
[TBL] [Abstract][Full Text] [Related]
80. Perylene and coronene derivatives binding to G-rich promoter oncogene sequences efficiently reduce their expression in cancer cells.
Micheli E; Altieri A; Cianni L; Cingolani C; Iachettini S; Bianco A; Leonetti C; Cacchione S; Biroccio A; Franceschin M; Rizzo A
Biochimie; 2016 Jun; 125():223-31. PubMed ID: 27086081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
